Product Reports Resources Pricing Login Book a demo

Mirendil

Biotech & Life Sciences · San Francisco, United States · Founded 2026

Mirendil is an AI startup dedicated to developing advanced artificial intelligence models to accelerate scientific breakthroughs in biology and materials science. The company is part of a growing movement of 'neo-labs,' which are specialized AI ventures founded by researchers from major AI laboratories. These startups focus on niche applications rather than competing in the general-purpose AI model space. Mirendil aims to address the slow and expensive nature of traditional research and development by creating AI that can act as a "scientific co-pilot," speeding up the discovery of new drugs and materials. Founded in 2026 by former researchers from Anthropic, Mirendil is led by CEO Behnam Neyshabur and CTO Harsh Mehta. Neyshabur previously headed the scientific AI reasoning team at Anthropic and spent over five years at Google DeepMind, while Mehta was a senior research scientist at Anthropic. The founding team also includes Shayan Salehian, formerly of xAI, and Tara Rezaei, a former OpenAI intern. The founders departed Anthropic in December 2025 to establish the San Francisco-based company. Shortly after its founding, Mirendil entered into negotiations for a significant funding round of $175 million, which would place the company's valuation at $1 billion. This funding effort is reportedly being co-led by prominent venture capital firms Andreessen Horowitz and Kleiner Perkins, signaling strong investor confidence in the startup's specialized focus. The company's product is described as an AI discovery engine with models designed to simulate molecular interactions and navigate chemical space, potentially bridging the gap between simulation and robotic wet labs. Keywords: AI research, scientific discovery, biology, materials science, neo-labs, AI models, drug discovery, scientific reasoning, Behnam Neyshabur, Harsh Mehta, Anthropic alumni, Andreessen Horowitz, Kleiner Perkins, AI simulation, molecular interaction, chemical space, computational science

Investors

3 investors on Mirendil's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage

Global footprint

Where Mirendil has talent and traffic

Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Talent graph

The shape of Mirendil's talent

Dealroom maps Mirendil's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

3 team members profilednamed & role-tagged by Dealroom
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Mirendil's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Mirendil

An AI-synthesized read of the highest-engagement posts about Mirendil on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mirendil on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.